Hematological malignancies in chronic inflammatory bowel diseases: report of five cases and review of the literature.
Several forms of primary and secondary hematological malignancies were rarely observed during the clinical course of inflammatory bowel diseases (IBD). Patients needing a prolonged treatment with immunosuppressants, such as azathioprine or methotrexate, with familiarity and genetic predisposition seem to be at a higher risk of leukemia. On the other hand, asthenia, thickness, and fever may be the symptoms of the onset of each kind of hematological malignancy. The finding of anemia, alteration of leukocyte count and large undetermined cells may suggest increased probability of abnormal proliferation of a single white blood cell line. In this report, the occurrence of hematological malignancies is described in five patients affected by IBD (three with ulcerative colitis and two with Crohn's disease) attending our Gastroenterology Unit.
Crispino
Pietro
P
Gastroenterology Unit, Department of Clinical Sciences, University La Sapienza, Policlinico Umberto I, Viale del Policlinico 157, Rome 00161, Italy.
Pica
Roberta
R
Angelucci
Erika
E
Consolazio
Adriana
A
Rivera
Margherita
M
Cassieri
Claudio
C
Paoluzi
Paolo
P
D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000150:complications*; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000150:complications*; D015470:Leukemia, Myeloid, Acute / Q000150:complications*; D016393:Lymphoma, B-Cell / Q000150:complications*; D008297:Male; D008875:Middle Aged